Modular Medical (MODD) Proxy filing summary

Executive summary

• Annual Meeting scheduled for October 23, 2026, to be held virtually, with shareholders voting on key proposals including director elections, equity plan amendment, and auditor ratification.

• Shareholders of record as of September 10, 2026, are entitled to vote; 9,495,823 shares outstanding among 59 holders.

• Proxy materials and annual report are available online; voting can be done via Internet, phone, mail, or during the meeting.

Voting matters and shareholder proposals

• Election of six directors for one-year terms: James E. Besser, Paul DiPerna, Duane DeSisto, Steven Felsher, Philip Sheibley, and Ellen O'Connor Vos.

• Approval sought for amendment to the 2017 Equity Incentive Plan to increase shares available for issuance by 2,500,000.

• Ratification of Farber Hass Hurley LLP as independent registered public accounting firm for fiscal year ending March 31, 2027.

• Procedures for shareholder proposals and director nominations for the 2028 meeting are outlined.

Board of directors and corporate governance

• Board consists of six nominees, with a mix of executive and independent directors; two current directors declined re-election.

• Board committees (Audit, Compensation, Nominating and Governance) are composed entirely of independent directors.

• Lead independent director to be appointed after the meeting; board meetings and committee attendance exceeded 75% for all members.

• No family relationships or material legal proceedings involving directors or executive officers.